EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

The Absence of Intra‐Tumoral Tertiary Lymphoid Structures is Associated with a Worse Prognosis and mTOR Signaling Activation in Hepatocellular Carcinoma with Liver Transplantation: A Multicenter Retrospective Study

Jianhua Li iD, Li Zhang, Hao Xing iD, Yan Geng, Shaocheng Lv, Xiao Luo, Weiqiao He, Zhi Fu, Guangming Li, Bin Hu, Shengran Jiang, Zhe Yang und 12 weitere

Advanced Science · 2024

DOI: 10.1002/advs.202309348 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Advanced Science, 2024. Verfasst von Jianhua Li und 23 weiteren Autor:innen. Beteiligte Einrichtung: Liver Transplantation Center, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, 200040, P. R. China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, TOR Serine-Threonine Kinases, Liver Transplantation. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Clinical Research Plan of SHDC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tertiary lymphoid structure (TLS) can predict the prognosis and sensitivity of tumors to immune checkpoint inhibitors (ICIs) therapy, whether it can be noninvasively predicted by radiomics in hepatocellular carcinoma with liver transplantation (HCC‐LT) has not been explored. In this study, it is found that intra‐tumoral TLS abundance is significantly correlated with recurrence‐free survival (RFS) and overall survival (OS). Tumor tissues with TLS are characterized by inflammatory signatures and high infiltration of antitumor immune cells, while those without TLS exhibit uncontrolled cell cycle progression and activated mTOR signaling by bulk and single‐cell RNA‐seq analyses. The regulators involved in mTOR signaling (RHEB and LAMTOR4) and S‐phase (RFC2, PSMC2, and ORC5) are highly expressed in HCC with low TLS. In addition, the largest cohort of HCC patients is studied with available radiomics data, and a classifier is built to detect the presence of TLS in a non‐invasive manner. The classifier demonstrates remarkable performance in predicting intra‐tumoral TLS abundance in both training and test sets, achieving areas under receiver operating characteristic curve (AUCs) of 92.9% and 90.2% respectively. In summary, the absence of intra‐tumoral TLS abundance is associated with mTOR signaling activation and uncontrolled cell cycle progression in tumor cells, indicating unfavorable prognosis in HCC‐LT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsTOR Serine-Threonine KinasesLiver TransplantationTertiary Lymphoid StructuresSignal TransductionHumansPrognosisMaleRetrospective StudiesMiddle AgedFemaleAdultAgedSurvival Analysis

Stichwörter der Autor:innen

hepatocellular carcinomaliver transplantationmTOR signalingradiomicstertiary lymphoid structure

Substanzen

TOR Serine-Threonine KinasesMTOR protein, human

Autor:innen und Institutionen

  • Liver Transplantation Center, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, 200040, P. R. China.
  • Institute of Organ Transplantation, Fudan University, Shanghai, 200040, P. R. China.
  • Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, P. R. China.
  • Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, Shanghai, 200040, P. R. China.
  • Department of Hepatobiliary Surgery, Beijing Chaoyang Hospital affiliated to Capital Medical University, Beijing, 100020, P. R. China.
  • Academy for Engineering and Technology, Fudan University, Shanghai, 200032, P. R. China.

ORCID-Profile: Jianhua Li, Hao Xing

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Clinical Research Plan of SHDC
  • Greater Bay Area Institute of Precision Medicine (Guangzhou)
  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Li, J., Zhang, L., Xing, H., Geng, Y., Lv, S., Luo, X., He, W., Fu, Z., Li, G., Hu, B., Jiang, S., Yang, Z., Zhu, N., Zhang, Q., Zhao, J., Tao, Y., Shen, C., Li, R., Tang, F., …, & Wang, Z. (2024). The Absence of Intra‐Tumoral Tertiary Lymphoid Structures is Associated with a Worse Prognosis and mTOR Signaling Activation in Hepatocellular Carcinoma with Liver Transplantation: A Multicenter Retrospective Study. Advanced Science. https://doi.org/10.1002/advs.202309348

Vancouver

Li J, Zhang L, Xing H, Geng Y, Lv S, Luo X, et al. The Absence of Intra‐Tumoral Tertiary Lymphoid Structures is Associated with a Worse Prognosis and mTOR Signaling Activation in Hepatocellular Carcinoma with Liver Transplantation: A Multicenter Retrospective Study. Advanced Science. 2024. doi:10.1002/advs.202309348

BibTeX
@article{Li2024,
  author = {Li, Jianhua and Zhang, Li and Xing, Hao and Geng, Yan and Lv, Shaocheng and Luo, Xiao and He, Weiqiao and Fu, Zhi and Li, Guangming and Hu, Bin and Jiang, Shengran and Yang, Zhe and Zhu, Ningqi and Zhang, Quanbao and Zhao, Jing and Tao, Yifeng and Shen, Conghuan and Li, Ruidong and Tang, Feng and Zheng, Shusen and Bao, Yun and He, Qiang and Geng, Daoying and Wang, Zhengxin},
  title = {The Absence of Intra‐Tumoral Tertiary Lymphoid Structures is Associated with a Worse Prognosis and mTOR Signaling Activation in Hepatocellular Carcinoma with Liver Transplantation: A Multicenter Retrospective Study},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202309348}
}
Kostenlos starten →